Article
Effect of the common -866G/A polymorphism of the uncoupling protein 2 gene on weight loss and body composition under sibutramine therapy in an obese Taiwanese population.
Molecular diagnosis & therapy - 1 Apr 2010
Hsiao Tun-Jen, Wu Lawrence Shih-Hsin, Hwang Yuchi, Huang Shih-Yi, Lin Eugene
Abstract excerpt
BACKGROUND: Sibutramine, a serotonin and norepinephrine reuptake inhibitor, is used as an anti-obesity drug. Several pharmacogenetic studies have shown correlations between sibutramine effects and genetic variants, such as the 825C/T (rs5443) single nucleotide polymorphism (SNP) in the guanine nucleotide binding protein beta polypeptide 3 (GNB3) gene. OBJECTIVE: In this study, our goal was to investigate whether...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
